Skip to content

Archive for September 2016

SeptiCyte™ LAB Differentiates Sepsis from Infection-Negative Systemic Inflammation in Critically Ill Children

Results of a Pilot Study of SeptiCyte™ LAB in the Pediatric Setting Published in Critical Care Medicine SEATTLE, Sept. 22, 2016 /PRNewswire/ — Immunexpress, Inc., a molecular diagnostic company committed to improving outcomes for suspected sepsis patients and patients at risk of sepsis, announced today the publication, in Critical Care Medicine, of data demonstrating the ability…

Read More

Third National Forum on Sepsis

National Sepsis Forum 2016 September 12, 2016 New York, NY. CEO Roz Brandon invited to attend the 3rd National Sepsis Forum 2016 held by the Rory Staunton Foundation, “New Ideas on Sepsis.” New York State has led the country in its holistic approach to sepsis prevention, treatment and awareness. The Third National Forum will showcase the advances made by New…

Read More
Scroll To Top